We are live on
!
Find out more
DBG
De Burlo Group Portfolio holdings
AUM
$441M
1-Year Est. Return
21.21%
This Fund
S&P 500
This Quarter
Est. Return
+15.7%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$550M
AUM Growth
+$193M
(+54%)
Cap. Flow
+$66.2M
Cap. Flow
% of AUM
12.03%
Top 10 Holdings %
Top 10 Hldgs %
37.74%
Holding
95
New
27
Increased
22
Reduced
33
Closed
9
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Church & Dwight Co
CHD
|
+$17.8M |
| 2 |
Canadian Pacific Kansas City
CP
|
+$14.7M |
| 3 |
Abbott
ABT
|
+$14.4M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$14.3M |
| 5 |
Clorox
CLX
|
+$12.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$20.4M |
| 2 |
NextEra Energy
NEE
|
+$17.3M |
| 3 |
Adobe
ADBE
|
+$16.2M |
| 4 |
Lumentum
LITE
|
+$11.7M |
| 5 |
FISV
Fiserv Inc
FISV
|
+$11M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.99% |
| 2 | Healthcare | 19.78% |
| 3 | Financials | 11.08% |
| 4 | Industrials | 10.58% |
| 5 | Consumer Discretionary | 7.7% |
Similar funds
ECA
DWML
BOA
PLU
CPW
AWM
CAAM
SCP
De Burlo Group's Q3 2020 Portfolio in Review
As of Q3 2020, De Burlo Group held 95 positions worth $550M, up 54% from $357M the previous quarter. Its ten largest holdings account for 38% of the portfolio.
De Burlo Group deployed $66.2M of net new capital in Q3 2020, opening 27 new positions and adding to 22 existing holdings. Its largest new stake was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 34% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vertex Pharmaceuticals, an estimated $20.4M trimmed.
- De Burlo Group's largest Q3 2020 buy was Canadian Pacific Kansas City: 257,500 shares worth $15.7M.
- De Burlo Group added most to Church & Dwight Co in Q3 2020, an estimated $17.8M increase.
- De Burlo Group's biggest Q3 2020 reduction was Vertex Pharmaceuticals, cutting an estimated $20.4M.
- De Burlo Group fully exited Lumentum in Q3 2020, selling an estimated $11.7M.
- De Burlo Group's ten largest holdings make up 38% of its $550M portfolio in Q3 2020.
- De Burlo Group opened 27 new positions and closed 9 in Q3 2020.
- De Burlo Group's portfolio value rose 54% quarter-over-quarter to $550M.
Based on De Burlo Group's 13F filing for Q3 2020, filed 5 Nov 2020.